Jančuljak, D., Petravić, D., Lakušić, D. M., Lovrenčić-Huzjan, A., Baronica, K. B., Puretić, M. B., . . . Kes, V. B. Croatian guidelines for specific preventive treatment of migraine with monoclonal antibodies targeting calcitonin gene-related peptide (CGRP) (eptinezumab, fremanezumab, and galcanezumab) or the CGRP receptor (erenumab). Sestre Milosrdnice University hospital, Institute of Clinical Medical Research.
Chicago Style (17th ed.) CitationJančuljak, Davor, et al. Croatian Guidelines for Specific Preventive Treatment of Migraine with Monoclonal Antibodies Targeting Calcitonin Gene-related Peptide (CGRP) (eptinezumab, Fremanezumab, and Galcanezumab) or the CGRP Receptor (erenumab). Sestre Milosrdnice University hospital, Institute of Clinical Medical Research.
MLA (9th ed.) CitationJančuljak, Davor, et al. Croatian Guidelines for Specific Preventive Treatment of Migraine with Monoclonal Antibodies Targeting Calcitonin Gene-related Peptide (CGRP) (eptinezumab, Fremanezumab, and Galcanezumab) or the CGRP Receptor (erenumab). Sestre Milosrdnice University hospital, Institute of Clinical Medical Research.